On the other hand, the positive correlation between CRP and FGF19 observed two weeks post-transplant in patients with PBC and HCC may be related to specific clinical and pathophysiological factors characteristic of these primary diseases. The gene discussed is FGF19; the disease is hepatocellular carcinoma.